Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

INDUSTRY × Solid Tumor Cancer × ispinesib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor Cancer 2 Breast Neoplasms 2 Solid Tumours 1 Recurrence 1 Ovarian Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

ispinesib 2 Interleukin-18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00119171 2008-10-16

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer

NCT00169520 2008-10-16

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡